查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1967900

2026-2034年全球感染疾病呼吸系統疾病診斷市場規模、佔有率、趨勢和成長分析報告

Global Infectious Respiratory Disease Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，感染疾病呼吸道疾病診斷市場規模將從 2025 年的 577.4 億美元成長至 939.7 億美元，2026 年至 2034 年的複合年成長率為 5.56%。

由於包括流感、肺炎、結核病和其他病毒性疾病在內的呼吸道感染疾病日益普遍，全球感染疾病呼吸道疾病診斷市場正穩定擴張。都市化、空氣污染和季節性疫情爆發顯著推動了診斷需求。各國政府和醫療機構正優先建立早期檢測和監測系統，以防止感染擴散。分子診斷技術的進步，包括聚合酶鍊式反應（PCR）和快速抗原檢測，提高了檢測的準確性並加快了檢測速度。此外，新興國家檢測基礎設施的改善也加速了市場滲透。

人們對預防醫學和定期體檢的日益重視進一步推動了市場成長。醫院、診所和診斷檢查室正在投資自動化多功能檢測平台，以有效應對不斷成長的患者數量。人口老化加劇了呼吸道感染疾病的可及性。

對研發的持續投入維持了市場前景的穩健。就地檢驗和家用診斷試劑盒的推廣可望提升患者的便利性和可及性。人工智慧驅動的診斷解決方案有望提高診斷的準確性和預測能力。亞太地區和拉丁美洲地區的新興經濟體蘊藏著巨大的成長機會。總體而言，在技術創新和全球健康舉措的支持下，該市場有望實現長期持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球感染疾病呼吸道疾病診斷市場：依產品分類

  • 市場分析、洞察與預測
  • 設備（影像檢查、呼吸檢測設備及其他設備）
  • 消耗品
  • 服務

第5章 全球感染疾病呼吸道疾病診斷市場：依樣本分類

  • 市場分析、洞察與預測
  • 唾液
  • 鼻咽拭子（NPS）
  • 前鼻區
  • 血
  • 其他

第6章 全球感染疾病呼吸道疾病診斷市場：依應用分類

  • 市場分析、洞察與預測
  • COVID-19
  • 流感
  • 呼吸道融合細胞病毒（RSV）
  • 結核
  • 鏈球菌檢測
  • 其他呼吸系統疾病檢查

第7章 全球感染疾病呼吸道疾病診斷市場：依技術分類

  • 市場分析、洞察與預測
  • 免疫檢測
  • 分子診斷
  • 微生物學
  • 其他技術

第8章 全球感染疾病呼吸道疾病診斷市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 診斷檢查室
  • 醫生診所
  • 其他

第9章 全球感染疾病呼吸道疾病診斷市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott
    • Thermo Fisher Scientific Inc
    • Koninklijke Philips NV
    • F. Hoffmann-La Roche Ltd
    • BD
    • BioMAfA（C）Rieux SA
    • Bio-Rad Laboratories Inc
    • Quidel Corporation
    • Siemens Healthcare GmbH
    • Danaher
    • Qiagen
簡介目錄
Product Code: VMR11219207

The Infectious Respiratory Disease Diagnostics Market size is expected to reach USD 93.97 Billion in 2034 from USD 57.74 Billion (2025) growing at a CAGR of 5.56% during 2026-2034.

The Global Infectious Respiratory Disease Diagnostics Market is expanding steadily due to the rising prevalence of respiratory infections such as influenza, pneumonia, tuberculosis, and other viral diseases. Increasing urbanization, air pollution, and seasonal outbreaks are significantly contributing to diagnostic demand. Governments and healthcare institutions are prioritizing early detection and surveillance systems to prevent widespread transmission. Technological advancements in molecular diagnostics, including PCR and rapid antigen testing, are enhancing accuracy and turnaround time. Additionally, improved laboratory infrastructure in emerging economies is accelerating market penetration.

Growing awareness regarding preventive healthcare and routine screening programs is further strengthening market growth. Hospitals, clinics, and diagnostic laboratories are investing in automated and multiplex testing platforms to handle higher patient volumes efficiently. The aging population, which is more susceptible to respiratory infections, also drives consistent testing demand. Integration of digital health systems and data analytics improves disease tracking and outbreak management. Increasing collaborations between public health agencies and private diagnostic firms are supporting innovation and accessibility.

Future prospects for the market remain strong with continuous investments in research and development. The expansion of point-of-care testing and home-based diagnostic kits is expected to improve patient convenience and accessibility. Artificial intelligence-enabled diagnostic solutions are likely to enhance precision and predictive capabilities. Emerging economies in Asia-Pacific and Latin America present significant growth opportunities. Overall, the market is poised for sustained long-term growth supported by technological innovation and global health preparedness initiatives.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments)
  • Consumables
  • Services

By Sample

  • Saliva
  • Nasopharyngeal Swabs (NPS)
  • Anterior Nasal Region
  • Blood
  • Others

By Application

  • COVID-19
  • Influenza
  • Respiratory Syncytial Virus (RSV)
  • Tuberculosis
  • Streptococcus Testing
  • Other Respiratory Disease Testing

By Technology

  • Immunoassay
  • Molecular Diagnostics
  • Microbiology
  • Other Technologies

By End Use

  • Hospitals
  • Diagnostic Laboratories
  • Physician Offices
  • Others

COMPANIES PROFILED

  • Abbott, Thermo Fisher Scientific Inc, Koninklijke Philips NV, F HoffmannLa Roche Ltd, BD, bioMrieux SA, BioRad Laboratories Inc, Quidel Corporation, Siemens Healthcare GmbH, Danaher, Qiagen
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY SAMPLE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Sample
  • 5.2. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Nasopharyngeal Swabs (NPS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Anterior Nasal Region Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. COVID-19 Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Influenza Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Respiratory Syncytial Virus (RSV) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Tuberculosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Streptococcus Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.7. Other Respiratory Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Technology
  • 7.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Microbiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End Use
  • 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Physician Offices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product
    • 9.2.2 By Sample
    • 9.2.3 By Application
    • 9.2.4 By Technology
    • 9.2.5 By End Use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product
    • 9.3.2 By Sample
    • 9.3.3 By Application
    • 9.3.4 By Technology
    • 9.3.5 By End Use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product
    • 9.4.2 By Sample
    • 9.4.3 By Application
    • 9.4.4 By Technology
    • 9.4.5 By End Use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product
    • 9.5.2 By Sample
    • 9.5.3 By Application
    • 9.5.4 By Technology
    • 9.5.5 By End Use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product
    • 9.6.2 By Sample
    • 9.6.3 By Application
    • 9.6.4 By Technology
    • 9.6.5 By End Use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Abbott
    • 11.2.2 Thermo Fisher Scientific Inc
    • 11.2.3 Koninklijke Philips N.V
    • 11.2.4 F. Hoffmann-La Roche Ltd
    • 11.2.5 BD
    • 11.2.6 BioMAfA(C)Rieux SA
    • 11.2.7 Bio-Rad Laboratories Inc
    • 11.2.8 Quidel Corporation
    • 11.2.9 Siemens Healthcare GmbH
    • 11.2.10 Danaher
    • 11.2.11 Qiagen